P3 Technologies (P3T) – a leading pet health technology and solutions provider – recently announced the successful closure of a substantial $10 million investment round and the strategic acquisition of a leading veterinary pharmacy, which marks a significant milestone in the company’s growth and expansion strategy.
The $10 million funding round comes from strategic investors who recognize P3T’s innovative approach to pet healthcare delivery and its commitment to improving patient outcomes. This capital infusion will enable P3 Technologies to accelerate its mission of transforming the healthcare industry through technology-driven solutions and comprehensive patient care services.
Along with the investment, P3 Technologies acquired Heartland Veterinary Pharmacy and VetApproved Pharmacy. These two pharmacies have a strong track record of providing high-quality pharmaceutical services to the pet community. This deal aligns with P3T’s commitment to offering a seamless approach to healthcare, where pharmacy services play a pivotal role in pet care.
KEY QUOTES:
“We are truly excited about this significant injection of capital, which will empower us to further develop our cutting-edge technology and expand our reach to serve even more pet parents in need. This investment reaffirms our dedication to enhancing the pet health experience for both pet parents and their providers.”
“The addition of Heartland and VetApproved to the P3 family is a significant step forward in our mission to provide comprehensive pet healthcare solutions. This strategic move allows us to streamline our services and offer our clients a seamless experience, from prescriptions to insurance to care services.” The new funds and the acquisition will enable P3 Technologies to expand its services, invest in advanced technology, hire additional professionals, and continue to provide best-in-class care to its growing customer base.”
— P3T’s CEO, Rob Levin
